Insider buying last 90 days
No open-market insider purchases were filed for BBWI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every BBWI insider filing, plotted on the chart in Gekko.Open BBWI in Gekko
NYSE: BBWI
Bath & Body Works (BBWI) Stock Analysis & Forecast
Oct 12 close
$17.41+0.07 (+0.4%)
Gekko Brief
AI summaryOct 12 closeBath & Body Works draws attention this week mainly through product news rather than financial results. The Everyday Luxuries fragrance franchise is expanding with new scents, premium formats such as Eau de Parfum and Perfume Roll-On, and increased fragrance concentration, alongside the separate launch of Midnight Rouge across fine fragrance, body care and home fragrance. Coverage also notes the company leaning on upgraded formulas and packaging to support pricing as value-conscious consumers pressure broader sales, and references to an earlier share jump of 7.9% to 8.7% on quarterly EPS of $0.62 against an expected $0.24, even as revenue declined 2.3% year-over-year.
BBWI closes at $17.41, down 0.4%, sitting below both its 50-day average of $18.26 and its 200-day average of $19.84, with the shorter average itself below the longer one. The stock's one-month return is -6.2% and its one-year return is -32.4%, within a 52-week range of $14.28 to $27.40. The GekkoIndex reads 57, placing BBWI in the Neutral zone, down 3.2 over five days. Price sits 45% below Gekko Fair Value of $31.65.
The next earnings date falls on 19 November 2026, 37 days out and beyond a typical 20-trading-day hold; the prior report on 27 May 2026 produced a 14.8% reaction on an EPS beat of $0.32 versus $0.29 expected. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged +2.7% over 5 years, rising in 3 of them, a pattern worth noting alongside the consensus target of $24.06 from 17 covering firms.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Bath & Body Works price vs fair value
Close $17.41200-day averageGekko Fair Value $31.65
Bath & Body Works quick facts
- Market cap
- $3.51B
- P/E ratio
- 4.7
- Forward P/E
- 6.3
- EPS, TTM
- $3.80
- Revenue, TTM
- $7.21B
- Profit margin
- 10.8%
- Dividend yield
- 4.49%
- Beta
- 1.40
- Volume
- 4.86M avg 7.12M
- 1-year return
- −32.4%
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±8.5%
- 50-day average
- $18.26
- 200-day average
- $19.84
- Next earnings
- Nov 19 before open
- Shares outstanding
- 201.6M
Bath & Body Works swing-trade checklist
Bath & Body Works scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $17.41 is below the 50-day ($18.26) and 200-day ($19.84) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexmixed
57, Neutral
Reading 57 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
45.0% below
Price is 45% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 38 days
Next report Nov 19, 2026, 38 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.7% on average
From this point in the calendar, the next 20 trading days averaged +2.7% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Bath & Body Works stock chart and price history
Bath & Body Works closed at $17.41 on Oct 12, 2026, −32.4% over the past year, inside a 52-week range of $14.28 to $27.40.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −6.2%
- 3 months
- −13.1%
- 6 months
- −5.1%
- 1 year
- −32.4%
The full BBWI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open BBWI in Gekko
Follow Bath & Body Works through every session
Put BBWI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track BBWI in GekkoFree for 7 days. No credit card required.
About Bath & Body Works
Bath & Body Works sells personal care items and home scent products, with a lineup that runs from candles and diffusers to body lotions, washes, soaps, mists and eau de parfum. The company is recognized for these fragrance-driven goods, sold mainly under its own name, aimed at everyday shoppers looking for scented bath and home items.
Products reach customers through company-run stores and online channels across the United States and Canada, while international markets are served by outside partners operating under franchise, license and wholesale agreements. This structure lets the company keep a direct hand in its core North American business while extending its reach abroad through third parties.
The company traces its roots to 1963 and operates out of Columbus, Ohio. It previously went by the name L Brands before adopting its current name in August 2021. Its shares trade on the NYSE under the ticker BBWI.
- Listed
- NYSE
- Sector
- Retail trade
- Industry
- Specialty stores
- Website
- bbwinc.com
Bath & Body Works GekkoIndex: the smart money zone
Bath & Body Works’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57, in the Neutral zone, down 3.2 points over five sessions.
57Neutral
Down 3.2 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 63 | +1.7% | +5.3% | ||
| Accumulation | 278 | −0.2% | −1.2% | ||
| Neutral (current zone) | 320 | −0.8% | −3.9% | ||
| Distribution | 20 | −1.4% | −4.0% | ||
| Selling | 1 | Too few readings yet | |||
Average BBWI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the BBWI price, zone by zone.Track BBWI in Gekko
Is Bath & Body Works stock overvalued? Gekko Fair Value
Bath & Body Works trades 45.0% below Gekko Fair Value of $31.65, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Bath & Body Works shares are worth, recalculated every trading day.
$31.65
Gekko Fair Value, Oct 10, 2026
45.0% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open BBWI in Gekko
Bath & Body Works insider and Congress trading
No open-market insider purchases were filed for Bath & Body Works, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in BBWI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for BBWI, plotted on the chart in Gekko.Open BBWI in Gekko
Buybacks
Bath & Body Works has been buying back its own shares.
- Bought back, quarter ended May 2, 2026
- $3.00M
- As a share of market cap
- 0.09%
- Trailing four quarters
- $268.0M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds BBWI.
0added1opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Bath & Body Works earnings: next date and track record
Bath & Body Works reports on Nov 19, 2026, before the open (38 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 19, 2026
Expected before the open, 38 days away
- EPS estimate
- $0.11
- Revenue estimate
- $1.55B
6 of 8reports beat the EPS estimate
±12.1%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, May 27, 2026 AI summary
- What they said
- BBWI reported Q1 2026 net sales decline of 3% with adjusted EPS of $0.32, both ahead of expectations but below brand standards. The company is executing a 'consumer-first formula' transformation strategy. New moisturizing/revitalizing body care launches showed double-digit AUR and SKU productivity gains. Body care underperformed due to assortment missteps in everyday luxury franchise, which management identified and is actively correcting.
- Guidance
- Management reaffirmed full year 2026 net sales and EPS guidance. Strategy impact expected to build through 2026 and become more financially visible in 2027, suggesting near-term results remain pressured.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 27, 2026 | $0.32 est $0.29 | $1.38B est $1.36B | +14.8% |
| Mar 4, 2026 | $2.05 est $1.77 | $2.72B est $2.63B | −0.6% |
| Nov 20, 2025 | $0.35 est $0.38 | $1.59B est $1.62B | −29.4% |
| Aug 28, 2025 | $0.37 est $0.37 | $1.55B est $1.64B | −7.4% |
| May 29, 2025 | $0.49 est $0.42 | $1.42B est $1.42B | −7.7% |
| Feb 27, 2025 | $2.09 est $1.97 | $2.79B est $1.42B | −11.8% |
| Nov 25, 2024 | $0.49 est $0.47 | $1.61B est $1.58B | +14.7% |
| Aug 28, 2024 | $0.37 est $0.36 | $1.53B est $1.54B | −10.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Bath & Body Works stock forecast and analyst price targets
Analysts’ average 12-month price target for Bath & Body Works is $24.06, +38.2% from the last close, from 17 firms rating the stock in the last 90 days.
$24.06consensus 12-month target, +38.2% from the last close
Now $17.41Avg $24.06
Low $17High $30
Each firm’s latest rating in the last 90 days: 17 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 5 | Telsey Advisory | $22 | +26.4% |
| Sep 28 | Wells Fargo | $24 | +37.9% |
| Sep 15 | Argus Research | — | — |
| Sep 11 | Guggenheim | — | — |
| Sep 9 | BMO Capital | $20 | +14.9% |
−3.9%average 20-day move after past Neutral readings
+2.7%average move over the next 20 trading days in the last 5 years
±3.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Bath & Body Works seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Bath & Body Works averaged +2.7% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +4.3% | 4 of 5 |
| Next 10 trading days | +1.6% | 2 of 5 |
| Next 15 trading days | +0.4% | 1 of 5 |
| Next 20 trading days | +2.7% | 3 of 5 |
| Next 30 trading days | −1.4% | 3 of 5 |
For scale, BBWI’s typical 20-trading-day move in either direction is about 8.5%.
Bath & Body Works market cap and key statistics
Bath & Body Works’s market cap is $3.51B, with a P/E ratio of 4.7 and revenue of $7.21B over the last twelve months.
Valuation
- Market cap
- $3.51B
- P/E ratio
- 4.7
- Forward P/E
- 6.3
- EPS, TTM
- $3.80
- Gekko Fair Value
- $31.65
Trading
- Volume
- 4.86M
- Avg volume, 20 days
- 7.12M
- 52-week high
- $27.40
- 52-week low
- $14.28
- Shares outstanding
- 201.6M
Financials
- Revenue, TTM
- $7.21B
- Profit margin
- 10.8%
- Return on equity
- 0%
- Quarterly earnings growth, YoY
- +93.3%
Risk and income
- Beta
- 1.40
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±8.5%
- Dividend yield
- 4.49%
Bath & Body Works stock news this week
Coverage of Bath & Body Works this week reads positive: 2 positive, 2 neutral and 0 negative headlines.
- Bath & Body Works’ Everyday Luxuries Franchise Expands with New Fragrances, Premium Formats and Long-Lasting Performancehttps://www.bbwinc.com/, Oct 12
- Bath & Body Works Inc Share Price - BBWI, RNS News, Articles, Quotes, & Charts (NYSE:BBWI)Proactive financial news, Oct 9
- Bath & Body Works (BBWI) Surges 8.7%: Is This an Indication of Further Gains? (Revised)Zacks Investment Research, Oct 8
- Bath & Body Works Debuts Midnight Rouge Across Fine Fragrance, Body Care and Home Fragrancewww.bbwinc.com, Oct 7
- BBWI's Product Innovation Supports Pricing as Consumers Seek ValueZacks Investment Research, Oct 6
- Bath & Body Works (BBWI) Surges 8.7%: Is This an Indication of Further Gains?Zacks Investment Research, Oct 6
Bath & Body Works peers
Bath & Body Works’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| WMTWalmart | Neutral | 2.5% below |
| COSTCostco Wholesale | Neutral | 16.4% above |
| ORLYO'Reilly Automotive | Neutral | 4.7% below |
| TGTTarget | Accumulation | 5.7% above |
| CVNACarvana | Accumulation | 19.7% below |
| AZOAutoZone | Neutral | 28.5% below |
A peer links to its own page where one exists.
Bath & Body Works stock FAQ
What is Bath & Body Works’s market cap?
Bath & Body Works’s market cap is $3.51B at the Oct 12, 2026 close of $17.41, with 201.6M shares outstanding. The shares trade on a P/E ratio of 4.7.
What is the Bath & Body Works stock forecast?
The consensus analyst 12-month price target for Bath & Body Works is $24.06, +38.2% from the last close. Of the 17 firms that rated the stock in the last 90 days, 4 rate it a buy, 12 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Bath & Body Works stock overvalued or undervalued?
On Gekko’s estimate Bath & Body Works is undervalued: the Oct 12, 2026 close of $17.41 is 45.0% below Gekko Fair Value of $31.65. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Bath & Body Works report earnings next?
Bath & Body Works is expected to report on Nov 19, 2026, before the market opens (38 days away). Analysts expect earnings of $0.11 per share on revenue of $1.55B. Bath & Body Works beat the earnings estimate in 6 of its last 8 reports, moving 12.1% on average across the report.
What is Bath & Body Works’s 52-week high and low?
Bath & Body Works’s 52-week high is $27.40 and its 52-week low is $14.28; it closed at $17.41 on Oct 12, 2026, −32.4% over the past year. Over the last five years the shares peaked at $82.00 on Nov 18, 2021.
Is Bath & Body Works stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (fair value, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Bath & Body Works the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.